|
|
||||||||
Department of Neurology, School of Medicine, University of California, San Francisco, CA.
Address correspondence and reprint requests to Dr. Munsat, Tufts-New England Medical Center, Department of Neurology, 171 Harrison Avenue, Boston, MA 02111.
Amantadine and guanidine were evaluated in two groups of 10 amyotrophic lateral sclerosis patients each. In a double-blind, crossover design lasting 1 year, neither drug showed therapeutic benefit as compared to placebo.
This article has been cited by other articles:
![]() |
H. Mitsumoto, M. R. Hanson, and D. A. Chad Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials Arch Neurol, February 1, 1988; 45(2): 189 - 202. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |